<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03312556</url>
  </required_header>
  <id_info>
    <org_study_id>010189-1</org_study_id>
    <secondary_id>200124</secondary_id>
    <nct_id>NCT03312556</nct_id>
  </id_info>
  <brief_title>Treatment of Supine Hypertension in Autonomic Failure (CPAP)</brief_title>
  <official_title>Treatment of Supine Hypertension in Autonomic Failure With Continuous Positive Airway Pressure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vanderbilt University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Supine hypertension is a common problem that affects at least 50% of patients with primary&#xD;
      autonomic failure. Supine hypertension can be severe and complicates the treatment of&#xD;
      orthostatic hypotension. The purpose of this study is to assess whether continuous positive&#xD;
      airway pressure (CPAP) decreases blood pressure in autonomic failure patients with supine&#xD;
      hypertension.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Supine hypertension is a common problem that affects at least 50% of patients with primary&#xD;
      autonomic failure. Supine hypertension can be severe and complicates the treatment of&#xD;
      orthostatic hypotension. Drugs used for the treatment of orthostatic hypotension (eg,&#xD;
      fludrocortisone and pressor agents), worsen supine hypertension. High blood pressure may also&#xD;
      cause target organ damage in this group of patients. The pathophysiologic mechanisms causing&#xD;
      supine hypertension in patients with autonomic failure have not been defined.&#xD;
&#xD;
      This study will test the hypothesis that continuous positive airway pressure (CPAP) has an&#xD;
      acute lowering-BP effect in autonomic failure patients with supine hypertension. CPAP is a&#xD;
      widely-used treatment for sleep-related breathing disorders including sleep apnea, that uses&#xD;
      mild air pressure to keep the breathing airways open. It involves using a CPAP machine that&#xD;
      blows air into a tube connected to a mask placed over the nose, or nose and mouth. For these&#xD;
      studies, a commercial CPAP device will be used to apply pressure sequentially at 0, 4, 8, 12&#xD;
      and 16 cm H2O for 1-20 minute each. Depending on the BP response and tolerability to CPAP,&#xD;
      CPAP may be applied during the night using a CPAP level that was tolerable and showed a&#xD;
      BP-lowering effect during the acute test.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 21, 2017</start_date>
  <completion_date type="Anticipated">December 21, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 21, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Supine Systolic Blood Pressure</measure>
    <time_frame>12 hours</time_frame>
    <description>change in supine systolic blood pressure from baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Urinary volume</measure>
    <time_frame>12 hours</time_frame>
    <description>Nocturnal urinary volume</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Supine Hypertension</condition>
  <condition>Autonomic Failure</condition>
  <arm_group>
    <arm_group_label>Placebo pill or patch or sham CPAP</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo pill or patch or sham CPAP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CPAP (continuous positive airway pressure)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Continuous positive airway pressure during the night</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>continuous positive airway pressure (CPAP)</intervention_name>
    <description>Continuous positive airway pressure(CPAP) will be applied during the night starting from 20:00. CPAP level will be determined during an acute CPAP trial.</description>
    <arm_group_label>CPAP (continuous positive airway pressure)</arm_group_label>
    <other_name>CPAP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo pill or patch. Single dose</description>
    <arm_group_label>Placebo pill or patch or sham CPAP</arm_group_label>
    <other_name>placebo pill or patch</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with autonomic failure and with supine hypertension from all races&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  All medical students&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  High-risk patients (e.g. heart failure, symptomatic coronary artery disease, liver&#xD;
             impairment, history of stroke or myocardial infarction)&#xD;
&#xD;
          -  History of serious allergies or asthma.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Italo Biaggioni, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Emily C Smith, RN</last_name>
    <phone>615.875.1516</phone>
    <email>autonomics@vumc.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bonnie K Black, RN</last_name>
    <phone>615-343-6862</phone>
    <email>autonomics@vumc.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Autonomic Dysfunction Center/ Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emily C Smith, RN</last_name>
      <phone>615-875-1516</phone>
      <email>autonomics@vumc.org</email>
    </contact>
    <contact_backup>
      <last_name>Bonnie K Black, RN</last_name>
      <phone>615-343-6862</phone>
      <email>autonomics@vumc.org</email>
    </contact_backup>
    <investigator>
      <last_name>Bonnie K Black, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Luis E Okamoto, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Robertson, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Italo Biaggioni, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alfredo Gamboa, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cyndya A Shibao, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andre Diedrich, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>jorge Celedonio, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>October 12, 2017</study_first_submitted>
  <study_first_submitted_qc>October 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 17, 2017</study_first_posted>
  <last_update_submitted>September 27, 2021</last_update_submitted>
  <last_update_submitted_qc>September 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University Medical Center</investigator_affiliation>
    <investigator_full_name>Italo Biaggioni</investigator_full_name>
    <investigator_title>Professor of Medicine and Pharmacology</investigator_title>
  </responsible_party>
  <keyword>hypertension</keyword>
  <keyword>supine hypertension</keyword>
  <keyword>autonomic failure</keyword>
  <keyword>pure autonomic failure</keyword>
  <keyword>multiple system atrophy</keyword>
  <keyword>cpap</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pure Autonomic Failure</mesh_term>
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

